Livzon Pharmaceutical Group Inc. (1513.HK)
HKD 25.9
(0.39%)
HKD 25.9
(0.39%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.41 Billion CNY | 2.75% |
| 2022 | 2.35 Billion CNY | 3.69% |
| 2021 | 2.26 Billion CNY | -9.34% |
| 2020 | 2.5 Billion CNY | 44.55% |
| 2019 | 1.72 Billion CNY | 35.73% |
| 2018 | 1.27 Billion CNY | -77.47% |
| 2017 | 5.65 Billion CNY | 545.51% |
| 2016 | 876.48 Million CNY | 26.51% |
| 2015 | 692.79 Million CNY | 18.53% |
| 2014 | 584.5 Million CNY | -1.02% |
| 2013 | 590.55 Million CNY | 13.84% |
| 2012 | 518.75 Million CNY | 20.71% |
| 2011 | 429.74 Million CNY | -16.78% |
| 2010 | 516.41 Million CNY | -11.46% |
| 2009 | 583.27 Million CNY | 485.6% |
| 2008 | 99.6 Million CNY | -83.77% |
| 2007 | 613.75 Million CNY | 181.01% |
| 2006 | 218.4 Million CNY | 65.79% |
| 2005 | 131.73 Million CNY | -16.39% |
| 2004 | 157.55 Million CNY | -0.81% |
| 2003 | 158.83 Million CNY | 39.76% |
| 2002 | 113.65 Million CNY | 5.36% |
| 2001 | 107.86 Million CNY | 205.41% |
| 2000 | 35.31 Million CNY | 1581.46% |
| 1999 | -2.38 Million CNY | -126.48% |
| 1998 | 9 Million CNY | -76.05% |
| 1997 | 37.58 Million CNY | -44.34% |
| 1996 | 67.53 Million CNY | -8.19% |
| 1995 | 73.55 Million CNY | -30.81% |
| 1994 | 106.3 Million CNY | 0.0% |
| 1992 | 61.07 Million CNY | 1.85% |
| 1991 | 59.96 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 848.88 Million CNY | 98.4% |
| 2024 Q2 | 763.38 Million CNY | -10.07% |
| 2024 Q3 | 703.14 Million CNY | -7.89% |
| 2023 Q3 | 558.8 Million CNY | -19.03% |
| 2023 Q1 | 738.29 Million CNY | 54.47% |
| 2023 FY | 2.41 Billion CNY | 2.75% |
| 2023 Q2 | 690.13 Million CNY | -6.52% |
| 2023 Q4 | 427.86 Million CNY | -23.43% |
| 2022 Q1 | 723.5 Million CNY | 84.54% |
| 2022 Q3 | 547.45 Million CNY | -9.01% |
| 2022 Q4 | 477.94 Million CNY | -12.7% |
| 2022 Q2 | 601.65 Million CNY | -16.84% |
| 2022 FY | 2.35 Billion CNY | 3.69% |
| 2021 Q1 | 700.36 Million CNY | 101.66% |
| 2021 Q2 | 671.72 Million CNY | -4.09% |
| 2021 Q3 | 502.83 Million CNY | -25.14% |
| 2021 Q4 | 392.06 Million CNY | -22.03% |
| 2021 FY | 2.26 Billion CNY | -9.34% |
| 2020 Q3 | 583.59 Million CNY | -42.55% |
| 2020 FY | 2.5 Billion CNY | 44.55% |
| 2020 Q1 | 553.77 Million CNY | 40.21% |
| 2020 Q2 | 1.01 Billion CNY | 83.43% |
| 2020 Q4 | 347.29 Million CNY | -40.49% |
| 2019 Q1 | 462.13 Million CNY | 119.27% |
| 2019 FY | 1.72 Billion CNY | 35.73% |
| 2019 Q2 | 458.77 Million CNY | -0.73% |
| 2019 Q3 | 413.97 Million CNY | -9.77% |
| 2019 Q4 | 394.96 Million CNY | -4.59% |
| 2018 Q1 | 382.97 Million CNY | -23.13% |
| 2018 Q4 | 210.75 Million CNY | -32.63% |
| 2018 Q3 | 312.85 Million CNY | -14.96% |
| 2018 FY | 1.27 Billion CNY | -77.47% |
| 2018 Q2 | 367.9 Million CNY | -3.94% |
| 2017 Q4 | 498.21 Million CNY | -89.07% |
| 2017 Q2 | 285.04 Million CNY | -10.41% |
| 2017 Q3 | 4.55 Billion CNY | 1498.49% |
| 2017 Q1 | 318.15 Million CNY | 70.96% |
| 2017 FY | 5.65 Billion CNY | 545.51% |
| 2016 Q4 | 186.1 Million CNY | -18.08% |
| 2016 FY | 876.48 Million CNY | 26.51% |
| 2016 Q3 | 227.17 Million CNY | 3.64% |
| 2016 Q2 | 219.2 Million CNY | -10.16% |
| 2016 Q1 | 243.99 Million CNY | 76.46% |
| 2015 Q2 | 189.74 Million CNY | 1.13% |
| 2015 Q4 | 138.27 Million CNY | -21.95% |
| 2015 Q3 | 177.15 Million CNY | -6.63% |
| 2015 Q1 | 187.62 Million CNY | 80.5% |
| 2015 FY | 692.79 Million CNY | 18.53% |
| 2014 FY | 584.5 Million CNY | -1.02% |
| 2014 Q4 | 103.94 Million CNY | -23.4% |
| 2014 Q3 | 135.69 Million CNY | -29.09% |
| 2014 Q2 | 191.34 Million CNY | 24.64% |
| 2014 Q1 | 153.52 Million CNY | 8.01% |
| 2013 Q4 | 142.13 Million CNY | 1.6% |
| 2013 Q1 | 165.22 Million CNY | 70.28% |
| 2013 Q3 | 139.89 Million CNY | -2.38% |
| 2013 FY | 590.55 Million CNY | 13.84% |
| 2013 Q2 | 143.3 Million CNY | -13.27% |
| 2012 Q3 | 139.65 Million CNY | -2.65% |
| 2012 Q1 | 138.6 Million CNY | 59.24% |
| 2012 FY | 518.75 Million CNY | 20.71% |
| 2012 Q2 | 143.46 Million CNY | 3.5% |
| 2012 Q4 | 97.02 Million CNY | -30.52% |
| 2011 FY | 429.74 Million CNY | -16.78% |
| 2011 Q1 | 144.27 Million CNY | 29.23% |
| 2011 Q2 | 116.96 Million CNY | -18.93% |
| 2011 Q3 | 81.45 Million CNY | -30.36% |
| 2011 Q4 | 87.04 Million CNY | 6.85% |
| 2010 Q3 | 115.42 Million CNY | -17.63% |
| 2010 FY | 516.41 Million CNY | -11.46% |
| 2010 Q1 | 149.2 Million CNY | -4.25% |
| 2010 Q2 | 140.13 Million CNY | -6.08% |
| 2010 Q4 | 111.64 Million CNY | -3.28% |
| 2009 Q4 | 155.82 Million CNY | 23.19% |
| 2009 FY | 583.27 Million CNY | 485.6% |
| 2009 Q3 | 126.49 Million CNY | -20.76% |
| 2009 Q2 | 159.63 Million CNY | 12.96% |
| 2009 Q1 | 141.31 Million CNY | 1831.82% |
| 2008 Q3 | -276.11 Thousand CNY | -101.27% |
| 2008 Q2 | 21.68 Million CNY | -69.41% |
| 2008 Q1 | 70.87 Million CNY | -10.09% |
| 2008 FY | 99.6 Million CNY | -83.77% |
| 2008 Q4 | 7.31 Million CNY | 2749.26% |
| 2007 Q1 | 154.05 Million CNY | 36.81% |
| 2007 Q4 | 78.83 Million CNY | -69.54% |
| 2007 Q3 | 258.78 Million CNY | 111.98% |
| 2007 Q2 | 122.08 Million CNY | -20.75% |
| 2007 FY | 613.75 Million CNY | 181.01% |
| 2006 Q4 | 112.6 Million CNY | 250.98% |
| 2006 Q3 | 32.08 Million CNY | -11.98% |
| 2006 Q2 | 36.45 Million CNY | -2.18% |
| 2006 Q1 | 37.26 Million CNY | 9.65% |
| 2006 FY | 218.4 Million CNY | 65.79% |
| 2005 FY | 131.73 Million CNY | -16.39% |
| 2005 Q4 | 33.98 Million CNY | 114.99% |
| 2005 Q3 | 15.8 Million CNY | -63.35% |
| 2005 Q2 | 43.13 Million CNY | 11.15% |
| 2005 Q1 | 38.8 Million CNY | 28.04% |
| 2004 Q4 | 30.3 Million CNY | 13.58% |
| 2004 FY | 157.55 Million CNY | -0.81% |
| 2004 Q1 | 67.79 Million CNY | 18.78% |
| 2004 Q2 | 32.76 Million CNY | -51.68% |
| 2004 Q3 | 26.68 Million CNY | -18.55% |
| 2003 Q3 | 14.14 Million CNY | -72.85% |
| 2003 Q4 | 57.08 Million CNY | 303.51% |
| 2003 FY | 158.83 Million CNY | 39.76% |
| 2003 Q1 | 35.5 Million CNY | 301.29% |
| 2003 Q2 | 52.1 Million CNY | 46.77% |
| 2002 Q3 | 42.16 Million CNY | 30.75% |
| 2002 Q2 | 32.25 Million CNY | 6.15% |
| 2002 FY | 113.65 Million CNY | 5.36% |
| 2002 Q1 | 30.38 Million CNY | 0.0% |
| 2002 Q4 | 8.84 Million CNY | -79.02% |
| 2001 FY | 107.86 Million CNY | 205.41% |
| 2000 FY | 35.31 Million CNY | 1581.46% |
| 1999 FY | -2.38 Million CNY | -126.48% |
| 1998 FY | 9 Million CNY | -76.05% |
| 1997 FY | 37.58 Million CNY | -44.34% |
| 1996 FY | 67.53 Million CNY | -8.19% |
| 1995 FY | 73.55 Million CNY | -30.81% |
| 1994 FY | 106.3 Million CNY | 0.0% |
| 1992 FY | 61.07 Million CNY | 1.85% |
| 1991 FY | 59.96 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 143.01 Million HKD | -1588.745% |
| Grand Pharmaceutical Group Limited | 2.66 Billion HKD | 9.322% |
| Extrawell Pharmaceutical Holdings Limited | -8.16 Million HKD | 29689.665% |
| Wai Yuen Tong Medicine Holdings Limited | 40.88 Million HKD | -5807.8% |
| Qianhai Health Holdings Limited | -52.18 Million HKD | 4728.152% |
| Lee's Pharmaceutical Holdings Limited | 36.04 Million HKD | -6600.817% |
| Essex Bio-Technology Limited | 310.32 Million HKD | -678.239% |
| Tongfang Kontafarma Holdings Limited | - HKD | -Infinity% |
| PuraPharm Corporation Limited | -66.04 Million HKD | 3756.707% |
| SSY Group Limited | 1.63 Billion HKD | -47.361% |
| JBM (Healthcare) Limited | 174.2 Million HKD | -1286.36% |
| Jacobson Pharma Corporation Limited | 333.12 Million HKD | -624.983% |
| China Resources Pharmaceutical Group Limited | 12.14 Billion HKD | 80.118% |